The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.

P. Petborom (Nakhon Nayok, Thailand)

Source: International Congress 2017 – Pleural and mediastinal malignancies
Session: Pleural and mediastinal malignancies
Session type: Thematic Poster
Number: 4311
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Petborom (Nakhon Nayok, Thailand). The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.. 4311

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Year: 2012


Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020




Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Prognostic value of treatment outcomes patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Malignant pleural effusion survival prognostication in an Asian population
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019



Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009


Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Is comorbidity a good prognostic factor for malignant pleural mesothelioma?
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016


A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Malignant pleural mesothelioma clinical aspects and survival in 93 cases
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010